A New Medical Therapy for Multiple Endocrine Neoplasia Type 1?

Pancreatic neuroendocrine tumours (pNETs) are a major manifestation of multiple endocrine neoplasia type 1 (MEN1), and the most significant cause of morbidity and mortality in this disorder. There is some evidence that the early use of somatostatin analogues can retard progression, especially of sma...

Descripción completa

Detalles Bibliográficos
Autores principales: Boharoon, Hessa, Grossman, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2022
Materias:
Endocrine Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838189/
https://www.ncbi.nlm.nih.gov/pubmed/36694894
http://dx.doi.org/10.17925/EE.2022.18.2.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838189/
https://www.ncbi.nlm.nih.gov/pubmed/36694894
http://dx.doi.org/10.17925/EE.2022.18.2.86

Ejemplares similares